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Enhanced Surgical Site Infection Surveillance Following
Hysterectomy, Vascular, and Colorectal Surgery
Deborah S. Yokoe, MD, MPH;1 Yosef Khan, MBBS, MPH;2 Margaret A. Olsen, PhD, MPH;3 David C. Hooper, MD;4
Maurice Greenbaum, MD;5 Johanna Vostok, MPH;6 Julie Lankiewicz, MPH;6 Victoria J. Fraser, MD;3,7
Kurt B. Stevenson, MD, MPH2,8 for the Centers for Disease Control and Prevention Epicenters Program
objective. To evaluate the use of inpatient pharmacy and administrative data to detect surgical site infections (SSIs) following hyster-
ectomy and colorectal and vascular surgery.
design. Retrospective cohort study.
setting. Five hospitals affiliated with academic medical centers.
patients. Adults who underwent abdominal or vaginal hysterectomy, colorectal surgery, or vascular surgery procedures between July
1, 2003, and June 30, 2005.
methods. We reviewed the medical records of weighted, random samples drawn from 3,079 abdominal and vaginal hysterectomy, 4,748
colorectal surgery, and 3,332 vascular surgery procedures. We compared routine surveillance with screening of inpatient pharmacy data
and diagnosis codes and then performed medical record review to confirm SSI status.
results. Medical records from 823 hysterectomy, 736 colorectal surgery, and 680 vascular surgery procedures were reviewed. SSI rates
determined by antimicrobial- and/or diagnosis code–based screening followed by medical record review (enhanced surveillance) were
substantially higher than rates determined by routine surveillance (4.3% [95% confidence interval, 3.6%–5.1%] vs 2.7% for hysterectomies,
7.1% [95% confidence interval, 6.7%–8.2%] vs 2.0% for colorectal procedures, and 2.3% [95% confidence interval, 1.9%–2.9%] vs 1.4%
for vascular procedures). Enhanced surveillance had substantially higher sensitivity than did routine surveillance to detect SSI (92% vs 59%
for hysterectomies, 88% vs 22% for colorectal procedures, and 72% vs 43% for vascular procedures). A review of medical records confirmed
SSI for 31% of hysterectomies, 20% of colorectal procedures, and 31% of vascular procedures that met the enhanced screening criteria.
conclusion. Antimicrobial- and diagnosis code–based screening may be a useful method for enhancing and streamlining SSI surveillance
for a variety of surgical procedures, including those procedures targeted by the Centers for Medicare and Medicaid Services.
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Healthcare providers, quality-improvement groups, consum-
ers, payers, and legislators have become increasingly invested
in efforts aimed at preventing healthcare-associated infections
(HAIs), including surgical site infections (SSIs). Prevention
of SSI has been targeted by the Department of Health and
Human Services as a national priority.1 Several ongoing na-
tional quality-improvement efforts are focused on SSI pre-
vention, including the Surgical Care Improvement Project
(SCIP), a collaborative SSI prevention effort led by the Cen-
ters for Medicare and Medicaid Services (CMS) and other
organizations focused on quality improvement. In addition,
the updated CMS Inpatient Prospective Payment System will
require hospitals seeking full CMS reimbursement to submit
SSI outcome measures for colorectal and abdominal hyster-
ectomy procedures through the Centers for Disease Control
and Prevention (CDC) National Healthcare Safety Network
(NHSN), and hospitals’ SSI outcomes are likely to be included
in the metrics used by CMS to determine eligibility for full
reimbursement.
To prevent SSI and to assess the benefits of prevention
programs, infection-prevention staff must accurately and ef-
ficiently monitor SSI rates; however, conventional SSI sur-
veillance methods have some major limitations. The SSI sur-
veillance definitions and methods that are most commonly
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utilized by infection preventionists in US hospitals are those
of the CDC’s NHSN. Although NHSN definitions are stan-
dardized, methods for case finding and data accessibility can
vary substantially between hospitals and involve labor-inten-
sive application of infection definitions to large numbers of
patients by highly trained personnel. Because these definitions
require a review of medical records and include some data
elements that are prone to subjective interpretation, SSI sur-
veillance is both resource intensive, potentially diverting
scarce infection-prevention resources away from other HAI
prevention activities, and subject to interobserver variability.
For these reasons, the development of alternative or ad-
junctive surveillance strategies that are efficient and relatively
objective is an important step toward advancing SSI prevention.
Our previous work has demonstrated the superior sensitivity
of screening algorithms that utilize automated data from ad-
ministrative and inpatient pharmacy databases compared with
routine prospective surveillance for SSI detection following a
variety of surgical procedures including coronary artery bypass
graft procedures and total hip and knee arthroplasty.2,3 The
goal of this study is to evaluate the use of this SSI surveillance
method for other operations targeted by the SCIP, including
hysterectomy, colorectal, and vascular procedures.
patients and methods
Study Design and Study Population
We conducted a retrospective cohort study that included pa-
tients aged 18 years and older who underwent hysterectomy,
vascular surgery, or colorectal surgery procedures between
July 1, 2003, and June 30, 2005, at 5 hospitals affiliated with
the CDC Prevention Epicenters, a research consortium
funded by the CDC. Participating hospitals were eligible to
submit data for study procedures if during the study period
they had performed prospective SSI surveillance using NHSN
definitions for those procedures. Three hospitals contributed
data for all 3 procedure types, 1 hospital contributed colo-
rectal and vascular data, and 1 hospital contributed only hys-
terectomy data. Patients were included if they had been as-
signed an International Classification of Disease, Ninth
Revision, Clinical Modification (ICD-9-CM) procedure code
for a hysterectomy, vascular, or colorectal procedure included
in SCIP specifications.4 Research personnel retrospectively re-
viewed the medical records of all patients who had been clas-
sified as having an SSI through routine surveillance. In ad-
dition, research personnel reviewed the medical records of a
random sample of approximately 200 patients without a
known SSI who underwent study procedures at each center,
by sorting procedures performed on patients without a
known SSI in chronological order by operative date and then
selecting procedures for review at evenly spaced intervals.
Data Collection
Medical record review at all study sites was limited to inpatient
medical records. Patient records were retrospectively reviewed
for clinical evidence of SSI, according to NHSN criteria, during
the initial hospitalization for surgery and during any subse-
quent hospitalizations at the same hospital and within the sur-
veillance time period specified by NHSN definitions (ie, 30
days for procedures not involving implantation of prosthetic
material and 365 days for procedures involving implants). Any
SSI identified solely in the outpatient setting was excluded from
the analysis. In addition, records were reviewed for the presence
or absence of specific ICD-9-CM diagnosis codes suggestive of
SSI (postoperative infection: 998.5, 998.51, 998.59; implant or
graft infection: 996.60; vascular procedures: 996.62) for the
index hospitalization or any subsequent hospitalization within
the surveillance time period.
Pharmacy data were reviewed to determine whether intra-
venous or oral antimicrobial agents were administered on or
after a patient’s second postoperative day and during any
subsequent hospitalization during the appropriate surveil-
lance time period. Antimicrobial exposure intervals were cal-
culated as the number of days from the first day through the
final days of antimicrobial use, excluding the day of operation
and the first postoperative day in order to omit antimicrobials
administered for perioperative prophylaxis. It was not re-
quired that patients receive antimicrobial agents on each day
or the same agent throughout the interval. For example, a
patient who received cefazolin on postoperative days 3–5, no
antimicrobials on days 6 and 7, and an oral fluoroquinolone
on days 8–11 was considered to have had an antimicrobial
exposure interval of 9 days. We also identified patients who
received any oral or parenteral antimicrobial therapy during
a subsequent hospitalization in the same hospital within the
appropriate surveillance time period. Data regarding the use
of antiviral and antifungal agents were excluded.
At the onset of the study, 2 reviewers examined 10% of
the medical records selected for review in order to validate
data collection methods. All centers were required to achieve
interobserver kappa scores of 0.60 or greater before pro-
ceeding with additional data collection. All information was
entered into a Microsoft Access database. All patient iden-
tifiers were removed before data sets were submitted to the
study coordinating center. The study protocol was approved
by the institutional review boards of each participating center.
Data Analysis
Using previously described methods, we identified the anti-
microbial exposure thresholds with the best combinations of
sensitivity and specificity when fitted to a receiver operating
characteristic (ROC) curve.5 We selected a random sample of
operative procedures from the pool of procedures performed
on patients without known SSI at each hospital, and we ex-
amined the results of medical record reviews for these patients
to estimate the numbers for each of the cells in the 2-by-2
tables assessing SSI status versus the presence or absence of
screening criteria based on the sampling fraction for that
hospital. For example, if we reviewed the records of one-fifth
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table 1. Sensitivity (Sens; %) and Positive Predictive Value (PPV) of Routine Surveillance and Screening by
Antimicrobial Exposure and Diagnosis Codes for Identification of Surgical Site Infection (SSI) Following Hyster-






Surveillance method Sens PPV Sens PPV Sens PPV
Routine surveillance 59 99 22 93 43 73
SSI diagnosis code during the index hospital stay and/or
readmissions 55 64 45 39 72 31
Antimicrobial exposure above threshold during index hospital
stay and/or any antimicrobials during readmission 85 32 86 20 90 11
Antimicrobial exposure during any readmission 70 51 51 18 84 13
Antimicrobial exposure above threshold during index hospital
stay and/or any antimicrobials during readmission and/or SSI
diagnosis code for index hospital stay or readmission 92 31 88 20 90 10
of all vascular surgery procedures performed on patients
without a known SSI at hospital A, then the numbers within
each of the cells of the 2-by-2 SSI status versus screening
criteria tables were multiplied by 5 and then added to the
results for hospital A procedures with known SSI, generating
overall 2-by-2 table results for all vascular procedures per-
formed at hospital A. These results were used to estimate the
sensitivity and positive predictive values (PPVs) of routine
prospective surveillance, screening based on antimicrobial ex-
posure, diagnosis codes suggestive of infection, and combi-
nations of these. We chose as screening criteria for each pro-
cedure type the combination of antimicrobial exposure
thresholds and/or diagnosis codes suggestive of SSI with the
highest sensitivity and PPVs of 20% or greater.
The total number of SSIs not previously detected through
routine surveillance was estimated by multiplying the rate of
SSI identified by review of the medical records of the random
sample of patients not known to have an SSI based on routine
surveillance by the number of patients in the entire cohort
who were not known to have an SSI. This estimate was added
to the number of SSIs identified through routine surveillance
to calculate a revised SSI rate. Statistical testing was performed,
using SAS statistical software, version 9.2 (SAS Institute).
results
Hysterectomy
During the study period, 3,079 hysterectomies were per-
formed at the 4 medical centers that implemented routine
prospective SSI surveillance for these procedures (range,
161–1,496 procedures per hospital). Eighty-two SSIs were de-
tected through routine surveillance, including 43 superficial
incisional, 11 deep incisional, and 28 organ/space SSIs. A
retrospective review of the medical records of the random
sample of 741 patients who were not previously known to
have an SSI identified 15 additional SSIs (10 superficial in-
cisional, 2 deep incisional, and 3 organ/space SSIs). By ex-
trapolating these results to the entire study population, we
estimated a total of 143 SSIs. A total of 80% of SSIs were
detected after initial patient discharge.
The sensitivity of routine surveillance for the detection of
SSI after hysterectomy was 59% (range among the 4 hospitals,
0%–69%). Screening with SSI diagnosis codes during the ini-
tial surgery hospitalization or a rehospitalization during the
surveillance period had similar sensitivity (55%) and a PPV
of 64% to detect SSI. Criteria of an antimicrobial exposure
threshold of 3 days or more and/or receipt of at least 1 day
of antimicrobials during subsequent rehospitalizations had a
substantially higher sensitivity of 85% and a PPV of 32% to
detect SSI. Adding assignment of an ICD-9-CM diagnosis
code for infection to antimicrobial-based screening increased
sensitivity to 92% (range among the 4 hospitals, 89%–100%)
and caused a minimal decrease in PPV, to 31% (Table 1).
Screening for patients who had an antimicrobial exposure
threshold of 3 days or more and/or receipt of at least 1 day
of antimicrobials during a rehospitalization and/or receipt of
an ICD-9-CM diagnosis code for infection (subsequently re-
ferred to as enhanced surveillance) provided a revised SSI
rate of 4.3% (95% confidence interval, 3.6%–5.1%), com-
pared with an SSI rate of 2.7% with routine surveillance
(Figure 1). The SSI rates by infection depth with routine
versus enhanced surveillance were 1.3% versus 3.2% for su-
perficial incisional SSI, 0.4% versus 0.8% for deep incisional
SSI, and 0.9% versus 1.6% for organ/space SSI. A total of
14% of all hysterectomy procedures met the antimicrobial-
plus diagnosis code–based screening criterion.
Colorectal Procedures
A total of 4,748 colorectal procedures were performed at the
4 participating medical centers during the study period
(range, 300–1,666 procedures per hospital). Routine surveil-
lance identified 109 SSIs, although 7 cases that were desig-
nated as SSI during routine surveillance were reclassified as
no SSI on review of the records. The remaining 102 SSIs
included 44 superficial incisional, 18 deep incisional, and 40
enhanced ssi surveillance 771
figure 1. Rates of surgical site infection (including superficial in-
cisional, deep incisional, and organ/space infections) determined
with routine surveillance versus antimicrobial and/or diagnosis
code–based (enhanced) screening following vascular procedures, co-
lorectal procedures, and abdominal and vaginal hysterectomies.
organ/space SSIs. Research personnel reviewed a random
sample of 643 patients who were not previously known to
have SSI and found 41 additional SSIs (25 superficial inci-
sional, 1 deep incisional, and 15 organ/space SSIs). By ex-
trapolating these results to the entire study population, we
estimated a total of 398 SSIs. A total of 43% of SSIs were
detected after initial hospital discharge.
The sensitivity of routine surveillance for the detection of
SSI after colorectal procedures was 22% (range among the 4
hospitals, 8%–89%). Screening for SSI diagnosis codes during
the initial surgery hospitalization or during readmissions had
a higher sensitivity for detecting SSI (45%) than did routine
surveillance, although this method still missed more than half
of all SSIs. Screening for receipt of 7 days or more of anti-
microbials during the index hospitalization and/or at least 1
day of antimicrobials during a rehospitalization during the
surveillance period had a substantially higher sensitivity of 86%
and a PPV of 20%. When analysis of diagnosis codes was added
to the antimicrobial criteria, sensitivity improved to 88% with-
out affecting the PPV of 20% (Table 2). Screening that included
a review of the records of patients who had an antimicrobial
exposure threshold of at least 7 days and/or received at least
1 day of antimicrobials during a rehospitalization and/or were
assigned an ICD-9-CM diagnosis code for infection (enhanced
surveillance) resulted in a revised SSI rate of 7.1% (95% con-
fidence interval, 6.7%–8.2%), compared with an SSI rate of
2.0% with routine surveillance (Figure 1). The SSI rates by
infection depth with routine versus enhanced surveillance were
0.8% versus 4.1% for superficial incisional SSI, 0.3% versus
0.5% for deep incisional SSI, and 0.8% versus 2.8% for organ/
space SSI. Thirty-seven percent of all patients undergoing co-
lorectal procedures met the antimicrobial- plus diagnosis
code–based screening criterion.
Vascular Procedures
A total of 3,332 vascular procedures were performed during
the study period at the 4 participating medical centers (range,
580–3,332 procedures per hospital). Routine surveillance
identified 68 SSIs, although 20 of these were reclassified as
no SSI on review of the records. The remaining 48 SSIs in-
cluded 16 superficial incisional, 22 deep incisional, and 10
organ/space SSIs. The 20 instances of SSI misclassification
during routine surveillance occurred at 3 of the 4 hospitals,
mainly involving cases originally classified as superficial in-
cisional SSIs. Research personnel reviewed a random sample
of 612 patients who were not previously known to have SSI
and detected 11 additional SSIs (6 superficial incisional, 4
deep incisional, and 1 organ/space SSI). By extrapolating these
results to the entire study population, we estimated a total
of 107 SSIs. A total of 85% of SSIs were detected after initial
hospital discharge.
Routine surveillance detected 43% (range among the 4 hos-
pitals, 32%–63%) of SSIs after vascular procedures. Screening
for SSI diagnosis codes during the index surgery hospitalization
period or during readmissions within the surveillance period
had higher sensitivity to detect SSI than did routine surveillance
(72%) and a PPV of 31%. Screening for receipt of at least 1
day of antimicrobials during rehospitalization was more sen-
sitive (84%) but had a low PPV of 13%. The addition of
diagnosis codes to the antimicrobial exposure criterion im-
proved sensitivity to 90%, but at the cost of further lowering
PPV (Table 2). Screening for patients who received an ICD-
9-CM diagnosis code for infection (enhanced surveillance) pro-
vided a revised SSI rate of 2.3% (95% confidence interval,
1.9%–2.9%), compared with an SSI rate of 1.4% with routine
surveillance (Figure 1). The SSI rates by infection depth with
routine versus enhanced surveillance were 0.5% versus 0.9%
for superficial incisional SSIs, 0.7% versus 1.1% for deep in-
cisional SSIs, and unchanged at 0.3% for organ/space SSIs.
Eight percent of patients undergoing vascular procedures met
the diagnosis code–based screening criterion.
discussion
HAI surveillance is essential to guide and assess the effec-
tiveness of infection-prevention strategies. Increasingly, states
are requiring that hospitals report HAI rates; many of these
states require that these data be entered into the NHSN sys-
tem. Hospitals are also now required to report SSI data to
the NHSN for full CMS reimbursement, and hospital-specific
SSI rates will become available for public scrutiny. The need
for complete and accurate surveillance, however, must be
balanced with competing demands, including resources nec-
essary for implementing other HAI prevention efforts. To
avoid the paradoxical negative impact of increasing surveil-
lance requirements, it is essential that healthcare facilities ex-
plore methods of streamlining surveillance. The completeness
and consistency of traditional surveillance methods can be
limited by interobserver variability in classifying infections,
inconsistent access to information required for the applica-
tion of surveillance definitions, and fluctuations in the in-
tensity of surveillance efforts over time due to competing
772 infection control and hospital epidemiology august 2012, vol. 33, no. 8
table 2. Surgical Care Improvement Project (SCIP) Procedures and Enhanced Surgical Site Infection Screening Criteria with
the Best Combinations of Sensitivity and Positive Predictive Value (PPV) for Detecting Surgical Site Infections






Coronary artery bypass graft operations2 1. ≥9 days of antimicrobials during the index surgery
hospitalization AND/OR
2. Any antimicrobials during any readmission within the
surveillance period AND/OR
3. Infection diagnosis code for the index hospitalization or a
readmission
19.6
Total knee arthroplasty3 1. Infection diagnosis code for the index hospitalization or a
readmission
2.7
Total hip arthroplasty3 1. Infection diagnosis code for the index hospitalization or a
readmission
3.6
Hysterectomy 1. ≥3 days of antimicrobials during the index surgery
hospitalization AND/OR
2. Any antimicrobials during any readmission within the
surveillance period AND/OR
3. Infection diagnosis code for the index hospitalization or a
readmission within the surveillance period
13.7
Colorectal procedures 1. ≥7 days of antimicrobials during the index surgery
hospitalization AND/OR
2. Any antimicrobials during any readmission within the
surveillance period AND/OR
3. Infection diagnosis code for the index hospitalization or a
readmission within the surveillance period
36.9
Vascular procedures 1. Infection diagnosis code for the index hospitalization or a
readmission within the surveillance period
7.5
figure 2. Rates of deep incisional plus organ/space surgical site
infections determined using routine surveillance versus antimicro-
bial and/or diagnosis code–based (enhanced) screening following
vascular procedures, colorectal procedures, and abdominal and vag-
inal hysterectomies.
infection-prevention and infection-control priorities. This
variability can limit the ability to compare SSI outcomes be-
tween institutions and even within a hospital over time.
Diagnosis codes that are relatively specific for SSI can be
used to improve the poor performance of claims-based SSI
surveillance that has been reported in some studies.6,7 Anti-
microbial administration for patients who have recently un-
dergone surgical procedures can indicate clinicians’ suspi-
cions of SSI and may in some cases accurately reflect the
presence of an infection even when microbiologic sample
cultures are not obtained. Both antimicrobial- and diagnosis
code–based screening criteria depend on data that are au-
tomated in many hospitals and that could be utilized with
minimal effort to identify for targeted review the subset of
surgical patients most likely to have SSI. Following hyster-
ectomy procedures, for example, antimicrobial- and diagnosis
code–based screening identified the 14% of patients in which
92% of all SSIs occurred.
Prior studies have identified combinations of antimicrobial
exposure thresholds and diagnosis codes that are useful for
identifying SSI following a variety of surgical procedures in-
cluding coronary artery bypass graft operations, total hip and
knee arthroplasty, breast procedures, and cesarean deliveries
(Table 2).2,3 The results of this study similarly suggest that
the use of diagnosis codes and/or quantitative measurement
of antimicrobial exposure can be a useful surveillance screen-
ing strategy following hysterectomy, colorectal, and vascular
operations (Table 2). For these procedures, antimicrobial-
and/or diagnosis code–based screening criteria were more
sensitive than routine surveillance and detected many SSIs
enhanced ssi surveillance 773
missed by routine surveillance, including deep incisional and
organ/space SSIs (Figure 2).
Although the PPV of antimicrobial- and/or diagnosis
code–based screening ranged from a low of 20% for colorectal
procedures to a high of 31% for hysterectomy and vascular
procedures, focusing on the 8%–37% of postsurgical patients
whose cases met screening criteria would enable infection
preventionists to identify 1 true case of SSI out of every 3
hysterectomy, every 5 colorectal, and every 3 vascular pro-
cedures reviewed. Antimicrobial- and/or diagnosis code–based
screening performed before medical record review could po-
tentially both improve the completeness and consistency of
SSI surveillance and streamline surveillance efforts.
Our study has a number of limitations. First, our strategy
of reviewing all previously identified SSIs and extrapolating
the results to other procedures by using a review of only a
sample of these procedures may have impacted the accuracy
and generalizability of screening criteria results.
Second, the goal of this study was to assess overall per-
formance of screening criteria, and our ability to assess in-
terhospital variability in screening criteria performance is lim-
ited because sensitivity, specificity, and PPV estimates were
based on pooled results. In addition, the 5 study sites were
affiliated with academic medical centers, and additional eval-
uation may be required to assess the generalizability of this
surveillance method for use in community hospitals or
resource-limited settings.
Furthermore, coding and antimicrobial prescribing prac-
tices may vary over time. In particular, diagnosis codes that
negatively impact a hospital’s reimbursement may lead med-
ical record coders to avoid the use of these codes. The results
of this study are based on procedures performed between
2003 and 2005, and increased scrutiny of SSI outcomes since
that time may have impacted coding and antimicrobial ad-
ministration practices as well as the accuracy and complete-
ness of SSI surveillance in hospitals. The effectiveness of di-
agnosis code– and antimicrobial-based screening criteria
therefore must be periodically reassessed over time.
Finally, this method uses only the information that is avail-
able in inpatient data systems and does not identify patients
with SSIs that were detected and treated exclusively in the
ambulatory setting or at hospitals other than the hospital
where the operation was performed. Other strategies, such
as those that utilize claims data submitted to insurers (eg,
CMS or managed-care organizations), may provide alterna-
tive approaches for assessing postsurgical complications
across the continuum of health care.8-11
Antimicrobial- and diagnosis code–based screening appears
to be a useful method for enhancing and streamlining SSI
surveillance for a variety of surgical procedures, including the
procedures targeted by the SCIP, and it provides a substantially
different picture of the overall burden of SSI than does routine
surveillance. As US hospitals progress toward adopting health-
care information technology, it may become more straight-
forward for infection preventionists to incorporate inpatient
pharmacy and administrative data into automated SSI sur-
veillance algorithms that could also be utilized by NHSN and
state health departments to further standardize, validate, and
augment the quality of national SSI surveillance data.
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